Loading…
Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice
Intracerebral or intraperitoneal injections of brain extracts from the Alzheimer’s disease patients result in the acceleration of cerebral β-amyloidosis in transgenic mice. Earlier, we have found that intravenous injections of synthetic full-length amyloid-β (Aβ) comprising the isomerized Asp7 trigg...
Saved in:
Published in: | Neurotoxicity research 2016-05, Vol.29 (4), p.551-557 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Intracerebral or intraperitoneal injections of brain extracts from the Alzheimer’s disease patients result in the acceleration of cerebral β-amyloidosis in transgenic mice. Earlier, we have found that intravenous injections of synthetic full-length amyloid-β (Aβ) comprising the isomerized Asp7 trigger cerebral β-amyloidosis. In vitro studies have shown that isomerization of Asp7 promotes zinc-induced oligomerization of the Aβ metal-binding domain (Aβ
1–16
). Here we report that single intracerebral injection of the peptide Aβ
1–16
with isomerized Asp7 (
iso
Aβ
1–16
) but not the injection of Aβ
1–16
significantly increases amyloid burden in 5XFAD transgenic mice. Our results provide evidence for a role of
iso
Aβ
1–16
as a minimal seeding agent of Aβ aggregation in vivo. |
---|---|
ISSN: | 1029-8428 1476-3524 |
DOI: | 10.1007/s12640-016-9603-y |